Oxford Biomedica PLC Total Voting Rights (0198X)
May 03 2016 - 4:25AM
UK Regulatory
TIDMOXB
RNS Number : 0198X
Oxford Biomedica PLC
03 May 2016
Oxford BioMedica
Total Voting Rights
Oxford, UK - 3 May 2016 2016: Oxford BioMedica plc ("Oxford
BioMedica" or "the Company") (LSE: OXB), a leading gene and cell
therapy group, announces that in accordance with the FCA's
Disclosure and Transparency Rule 5.6.1, the Company's issued share
capital as at the close of business on 30 April 2016 consisted of
2,702,901,494 ordinary shares of 1 pence each ("Ordinary Shares").
There are no Ordinary Shares held in treasury.
Accordingly, the total number of voting rights in Oxford
BioMedica plc at the date of this notice is 2,702,901,494.
The above figure (2,702,901,494) may be used by shareholders as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to
their interest in, Oxford BioMedica plc under the FCA's Disclosure
and Transparency Rules.
- Ends -
For further information, please
contact:
Oxford BioMedica plc: Tel: +44 (0)1865
John Dawson, Chief Executive Officer 783 000
Tim Watts, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0)20
Mary-Jane Elliott/Matthew Neal/Chris 3709 5700
Welsh/Laura Thornton
Notes for editors
About Oxford BioMedica(R)
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy
company focused on developing life changing treatments for serious
diseases. Oxford BioMedica has built a sector leading lentiviral
vector delivery platform (LentiVector(R) ) through which the Group
develops in vivo and ex vivo products both in-house and with
partners. The Group has created a valuable proprietary portfolio of
gene and cell therapy product candidates in the areas of oncology,
ophthalmology and CNS disorders. The Group has also entered into a
number of partnerships, including with Novartis, Sanofi, GSK, and
Immune Design, through which it has long-term economic interests in
other potential gene and cell therapy products. Oxford BioMedica is
based across several locations in Oxfordshire, UK and employs more
than 230 people. Further information is available at
www.oxfordbiomedica.co.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVREAPSDEAEKEEF
(END) Dow Jones Newswires
May 03, 2016 04:25 ET (08:25 GMT)
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Sep 2023 to Sep 2024